C Mark Eppler

Title: C Mark Eppler: Innovator in Opioid Receptor Research

Introduction

C Mark Eppler is a notable inventor based in Langhorne, Pennsylvania. He has made significant contributions to the field of biomedical research, particularly in the area of opioid receptors. His work has implications for understanding pain management and developing new therapeutic strategies.

Latest Patents

C Mark Eppler holds a patent for the "Mu-subtype opioid receptor." This patent involves isolated DNA encoding mu-subtype opioid receptor polypeptides. It also includes recombinant cloning vectors that incorporate this DNA, as well as cells that utilize these vectors. Furthermore, the patent discloses methods for producing these receptors and purifying them from both native and heterologous sources.

Career Highlights

Throughout his career, C Mark Eppler has focused on advancing the understanding of opioid receptors. His research has contributed to the development of new approaches in pain management and addiction treatment. With a patent portfolio that includes innovative techniques and methodologies, he has established himself as a key figure in his field.

Collaborations

C Mark Eppler has collaborated with esteemed colleagues such as George R Uhl and Jai-Bel Wang. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in opioid receptor studies.

Conclusion

C Mark Eppler's work in the field of opioid receptor research exemplifies the impact of innovative thinking in biomedical science. His contributions continue to influence the development of new therapeutic approaches for pain management and addiction.